Evidence map›Paper›PMID 29473935›Full record

ArticleGenetics and molecular biology

Dyslexia risk variant rs600753 is linked with dyslexia-specific differential allelic expression of DYX1C1.

Bent Müller, Johannes Boltze, Ivonne Czepezauer, Volker Hesse, LEGASCREEN Consortium, Arndt Wilcke, Holger Kirsten

Open access · goldAbstract read
In one paragraph

Article in Genetics and molecular biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bent MüllerFraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Johannes BoltzeFraunhofer Research Institution for Marine Biotechnology, Department of Medical Cell Technology, Lübeck, Germany.
Ivonne CzepezauerFraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Volker HesseGerman Center for Growth, Development and Health Encouragement in Childhood and Adolescence, Berlin, Germany.
LEGASCREEN Consortium
Arndt WilckeFraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Holger KirstenFraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Fraunhofer Institute for Cell Therapy and Immunology · DECharité - Universitätsmedizin Berlin · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing number of genetic variants involved in dyslexia development were discovered during the last years, yet little is known about the molecular functional mechanisms of these SNPs. In this study we investigated whether dyslexia candidate SNPs have a direct, disease-specific effect on local expression levels of the assumed target gene by using a differential allelic expression assay. In total, 12 SNPs previously associated with dyslexia and related phenotypes were suitable for analysis. Transcripts corresponding to four SNPs were sufficiently expressed in 28 cell lines originating from controls and a family affected by dyslexia. We observed a significant effect of rs600753 on expression levels of DYX1C1 in forward and reverse sequencing approaches. The expression level of the rs600753 risk allele was increased in the respective seven cell lines from members of the dyslexia family which might be due to a disturbed transcription factor binding sites. When considering our results in the context of neuroanatomical dyslexia-specific findings, we speculate that this mechanism may be part of the pathomechanisms underlying the dyslexia-specific brain phenotype. Our results suggest that allele-specific DYX1C1 expression levels depend on genetic variants of rs600753 and contribute to dyslexia. However, these results are preliminary and need replication.

Identifiers

PMID29473935
PMCPMC5901500
OpenAlexW2789801293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.